nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCG5—prostate cancer	0.236	0.562	CbGaD
Ezetimibe—UGT2B15—prostate cancer	0.168	0.4	CbGaD
Ezetimibe—ABCC3—Conjugated Estrogens—prostate cancer	0.023	0.0672	CbGbCtD
Ezetimibe—SLCO1B1—Cabazitaxel—prostate cancer	0.0186	0.0544	CbGbCtD
Ezetimibe—SLCO1B1—Estrone—prostate cancer	0.0182	0.0532	CbGbCtD
Ezetimibe—CYP3A4—prostate cancer	0.0158	0.0377	CbGaD
Ezetimibe—UGT1A1—Estradiol—prostate cancer	0.0151	0.0441	CbGbCtD
Ezetimibe—ABCG2—Cabazitaxel—prostate cancer	0.0148	0.0432	CbGbCtD
Ezetimibe—UGT2B7—Epirubicin—prostate cancer	0.0146	0.0428	CbGbCtD
Ezetimibe—ABCG2—Estrone—prostate cancer	0.0144	0.0422	CbGbCtD
Ezetimibe—ABCC2—Ethinyl Estradiol—prostate cancer	0.0142	0.0416	CbGbCtD
Ezetimibe—ABCC3—Etoposide—prostate cancer	0.0132	0.0385	CbGbCtD
Ezetimibe—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0119	0.0348	CbGbCtD
Ezetimibe—ABCC2—Conjugated Estrogens—prostate cancer	0.0104	0.0306	CbGbCtD
Ezetimibe—SLCO1B1—Estradiol—prostate cancer	0.0104	0.0305	CbGbCtD
Ezetimibe—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0099	0.029	CbGbCtD
Ezetimibe—UGT1A1—Etoposide—prostate cancer	0.00983	0.0288	CbGbCtD
Ezetimibe—ABCG2—Conjugated Estrogens—prostate cancer	0.00944	0.0276	CbGbCtD
Ezetimibe—ABCC3—Doxorubicin—prostate cancer	0.00898	0.0263	CbGbCtD
Ezetimibe—ABCG2—Mitoxantrone—prostate cancer	0.00858	0.0251	CbGbCtD
Ezetimibe—ABCG2—Estradiol—prostate cancer	0.00828	0.0243	CbGbCtD
Ezetimibe—ABCB1—Estramustine—prostate cancer	0.00807	0.0236	CbGbCtD
Ezetimibe—ABCC2—Etoposide—prostate cancer	0.00598	0.0175	CbGbCtD
Ezetimibe—ABCC2—Docetaxel—prostate cancer	0.00547	0.016	CbGbCtD
Ezetimibe—ABCG2—Etoposide—prostate cancer	0.00541	0.0158	CbGbCtD
Ezetimibe—ABCB1—Cabazitaxel—prostate cancer	0.00532	0.0156	CbGbCtD
Ezetimibe—CYP3A4—Bicalutamide—prostate cancer	0.0052	0.0152	CbGbCtD
Ezetimibe—ABCB1—Estrone—prostate cancer	0.0052	0.0152	CbGbCtD
Ezetimibe—ABCG2—Docetaxel—prostate cancer	0.00495	0.0145	CbGbCtD
Ezetimibe—CYP3A4—Estramustine—prostate cancer	0.00484	0.0142	CbGbCtD
Ezetimibe—ABCB1—Ethinyl Estradiol—prostate cancer	0.00464	0.0136	CbGbCtD
Ezetimibe—CYP3A4—Flutamide—prostate cancer	0.00431	0.0126	CbGbCtD
Ezetimibe—CYP3A4—Abiraterone—prostate cancer	0.00431	0.0126	CbGbCtD
Ezetimibe—ABCG8—prostate gland—prostate cancer	0.00415	0.113	CbGeAlD
Ezetimibe—ABCC2—Doxorubicin—prostate cancer	0.00408	0.0119	CbGbCtD
Ezetimibe—ABCG2—Doxorubicin—prostate cancer	0.00369	0.0108	CbGbCtD
Ezetimibe—ABCB1—Conjugated Estrogens—prostate cancer	0.0034	0.00996	CbGbCtD
Ezetimibe—CYP3A4—Cabazitaxel—prostate cancer	0.00319	0.00933	CbGbCtD
Ezetimibe—CYP3A4—Estrone—prostate cancer	0.00312	0.00912	CbGbCtD
Ezetimibe—ABCB1—Mitoxantrone—prostate cancer	0.00309	0.00906	CbGbCtD
Ezetimibe—ABCB1—Estradiol—prostate cancer	0.00299	0.00875	CbGbCtD
Ezetimibe—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00278	0.00813	CbGbCtD
Ezetimibe—ABCB1—Prednisone—prostate cancer	0.00257	0.00752	CbGbCtD
Ezetimibe—UGT1A1—urine—prostate cancer	0.00252	0.0686	CbGeAlD
Ezetimibe—CYP3A4—Conjugated Estrogens—prostate cancer	0.00204	0.00597	CbGbCtD
Ezetimibe—ABCB1—Etoposide—prostate cancer	0.00195	0.00571	CbGbCtD
Ezetimibe—NPC1L1—testis—prostate cancer	0.00193	0.0525	CbGeAlD
Ezetimibe—CYP3A4—Mitoxantrone—prostate cancer	0.00185	0.00543	CbGbCtD
Ezetimibe—CYP3A4—Estradiol—prostate cancer	0.00179	0.00524	CbGbCtD
Ezetimibe—ABCB1—Docetaxel—prostate cancer	0.00178	0.00522	CbGbCtD
Ezetimibe—UGT2B15—prostate gland—prostate cancer	0.00174	0.0474	CbGeAlD
Ezetimibe—CYP3A4—Prednisone—prostate cancer	0.00154	0.00451	CbGbCtD
Ezetimibe—SOAT1—prostate gland—prostate cancer	0.0015	0.0408	CbGeAlD
Ezetimibe—ANPEP—prostate gland—prostate cancer	0.00143	0.039	CbGeAlD
Ezetimibe—ABCB1—Doxorubicin—prostate cancer	0.00133	0.00389	CbGbCtD
Ezetimibe—SOAT1—seminal vesicle—prostate cancer	0.00127	0.0345	CbGeAlD
Ezetimibe—ANPEP—seminal vesicle—prostate cancer	0.00121	0.033	CbGeAlD
Ezetimibe—CYP3A4—Etoposide—prostate cancer	0.00117	0.00342	CbGbCtD
Ezetimibe—UGT2B15—urethra—prostate cancer	0.00117	0.0317	CbGeAlD
Ezetimibe—CYP3A4—Docetaxel—prostate cancer	0.00107	0.00313	CbGbCtD
Ezetimibe—UGT2B7—prostate gland—prostate cancer	0.00106	0.029	CbGeAlD
Ezetimibe—ANPEP—epithelium—prostate cancer	0.00105	0.0287	CbGeAlD
Ezetimibe—SOAT1—renal system—prostate cancer	0.00102	0.0278	CbGeAlD
Ezetimibe—SOAT1—urethra—prostate cancer	0.001	0.0273	CbGeAlD
Ezetimibe—ANPEP—renal system—prostate cancer	0.000977	0.0266	CbGeAlD
Ezetimibe—ANPEP—urethra—prostate cancer	0.00096	0.0261	CbGeAlD
Ezetimibe—UGT1A1—prostate gland—prostate cancer	0.000905	0.0246	CbGeAlD
Ezetimibe—CYP3A4—urine—prostate cancer	0.000808	0.022	CbGeAlD
Ezetimibe—CYP3A4—Doxorubicin—prostate cancer	0.000797	0.00233	CbGbCtD
Ezetimibe—SOAT1—bone marrow—prostate cancer	0.000773	0.021	CbGeAlD
Ezetimibe—ANPEP—bone marrow—prostate cancer	0.000739	0.0201	CbGeAlD
Ezetimibe—UGT2B7—renal system—prostate cancer	0.000726	0.0197	CbGeAlD
Ezetimibe—ABCC3—prostate gland—prostate cancer	0.000715	0.0194	CbGeAlD
Ezetimibe—SOAT1—testis—prostate cancer	0.00066	0.018	CbGeAlD
Ezetimibe—ANPEP—testis—prostate cancer	0.000632	0.0172	CbGeAlD
Ezetimibe—UGT1A1—renal system—prostate cancer	0.000617	0.0168	CbGeAlD
Ezetimibe—ABCC2—prostate gland—prostate cancer	0.000571	0.0155	CbGeAlD
Ezetimibe—SLCO1B1—renal system—prostate cancer	0.000513	0.014	CbGeAlD
Ezetimibe—ABCC3—renal system—prostate cancer	0.000487	0.0132	CbGeAlD
Ezetimibe—SOAT1—lymph node—prostate cancer	0.000479	0.013	CbGeAlD
Ezetimibe—UGT2B7—testis—prostate cancer	0.000469	0.0128	CbGeAlD
Ezetimibe—ANPEP—lymph node—prostate cancer	0.000458	0.0125	CbGeAlD
Ezetimibe—ABCG2—prostate gland—prostate cancer	0.000416	0.0113	CbGeAlD
Ezetimibe—ABCC2—renal system—prostate cancer	0.000389	0.0106	CbGeAlD
Ezetimibe—ABCG2—seminal vesicle—prostate cancer	0.000352	0.00958	CbGeAlD
Ezetimibe—ABCC3—testis—prostate cancer	0.000315	0.00856	CbGeAlD
Ezetimibe—ABCG2—urethra—prostate cancer	0.000279	0.00758	CbGeAlD
Ezetimibe—ABCC2—testis—prostate cancer	0.000252	0.00684	CbGeAlD
Ezetimibe—Flunarizine—CYP2A6—prostate cancer	0.000234	0.229	CrCbGaD
Ezetimibe—ABCC3—lymph node—prostate cancer	0.000228	0.00621	CbGeAlD
Ezetimibe—Pimozide—CYP3A5—prostate cancer	0.000223	0.218	CrCbGaD
Ezetimibe—ABCG2—bone marrow—prostate cancer	0.000215	0.00584	CbGeAlD
Ezetimibe—ABCB1—prostate gland—prostate cancer	0.000205	0.00559	CbGeAlD
Ezetimibe—CYP3A4—renal system—prostate cancer	0.000198	0.00538	CbGeAlD
Ezetimibe—ABCG2—testis—prostate cancer	0.000183	0.00499	CbGeAlD
Ezetimibe—ABCC2—lymph node—prostate cancer	0.000182	0.00496	CbGeAlD
Ezetimibe—ABCB1—seminal vesicle—prostate cancer	0.000174	0.00472	CbGeAlD
Ezetimibe—Flunarizine—CYP1A1—prostate cancer	0.000164	0.16	CrCbGaD
Ezetimibe—Pimozide—CYP2E1—prostate cancer	0.000153	0.15	CrCbGaD
Ezetimibe—Pimozide—CYP2C19—prostate cancer	0.000152	0.148	CrCbGaD
Ezetimibe—ABCB1—epithelium—prostate cancer	0.000151	0.0041	CbGeAlD
Ezetimibe—ABCB1—renal system—prostate cancer	0.00014	0.00381	CbGeAlD
Ezetimibe—ABCB1—urethra—prostate cancer	0.000137	0.00374	CbGeAlD
Ezetimibe—ABCG2—lymph node—prostate cancer	0.000133	0.00362	CbGeAlD
Ezetimibe—ABCB1—bone marrow—prostate cancer	0.000106	0.00288	CbGeAlD
Ezetimibe—Pimozide—CYP3A4—prostate cancer	9.64e-05	0.0944	CrCbGaD
Ezetimibe—ABCB1—testis—prostate cancer	9.05e-05	0.00246	CbGeAlD
Ezetimibe—ABCB1—lymph node—prostate cancer	6.56e-05	0.00178	CbGeAlD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	3.35e-05	0.000324	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Doxorubicin—prostate cancer	3.34e-05	0.000324	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Epirubicin—prostate cancer	3.34e-05	0.000323	CcSEcCtD
Ezetimibe—Anaphylactic shock—Docetaxel—prostate cancer	3.34e-05	0.000323	CcSEcCtD
Ezetimibe—Discomfort—Capecitabine—prostate cancer	3.33e-05	0.000323	CcSEcCtD
Ezetimibe—Infection—Docetaxel—prostate cancer	3.31e-05	0.000321	CcSEcCtD
Ezetimibe—Sinusitis—Epirubicin—prostate cancer	3.31e-05	0.000321	CcSEcCtD
Ezetimibe—Feeling abnormal—Etoposide—prostate cancer	3.31e-05	0.00032	CcSEcCtD
Ezetimibe—Diarrhoea—Mitoxantrone—prostate cancer	3.3e-05	0.00032	CcSEcCtD
Ezetimibe—Dry mouth—Capecitabine—prostate cancer	3.29e-05	0.000319	CcSEcCtD
Ezetimibe—Vomiting—Estradiol—prostate cancer	3.29e-05	0.000319	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Etoposide—prostate cancer	3.28e-05	0.000318	CcSEcCtD
Ezetimibe—Nervous system disorder—Docetaxel—prostate cancer	3.27e-05	0.000317	CcSEcCtD
Ezetimibe—Ill-defined disorder—Prednisone—prostate cancer	3.27e-05	0.000317	CcSEcCtD
Ezetimibe—Thrombocytopenia—Docetaxel—prostate cancer	3.27e-05	0.000316	CcSEcCtD
Ezetimibe—Rash—Estradiol—prostate cancer	3.26e-05	0.000316	CcSEcCtD
Ezetimibe—Infestation—Doxorubicin—prostate cancer	3.26e-05	0.000316	CcSEcCtD
Ezetimibe—Infestation NOS—Doxorubicin—prostate cancer	3.26e-05	0.000316	CcSEcCtD
Ezetimibe—Dermatitis—Estradiol—prostate cancer	3.26e-05	0.000316	CcSEcCtD
Ezetimibe—Anaemia—Prednisone—prostate cancer	3.26e-05	0.000316	CcSEcCtD
Ezetimibe—Confusional state—Capecitabine—prostate cancer	3.26e-05	0.000316	CcSEcCtD
Ezetimibe—Headache—Estradiol—prostate cancer	3.24e-05	0.000314	CcSEcCtD
Ezetimibe—Skin disorder—Docetaxel—prostate cancer	3.24e-05	0.000314	CcSEcCtD
Ezetimibe—Angioedema—Prednisone—prostate cancer	3.22e-05	0.000312	CcSEcCtD
Ezetimibe—Infection—Capecitabine—prostate cancer	3.21e-05	0.000311	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Doxorubicin—prostate cancer	3.2e-05	0.00031	CcSEcCtD
Ezetimibe—Urticaria—Etoposide—prostate cancer	3.19e-05	0.000309	CcSEcCtD
Ezetimibe—Jaundice—Doxorubicin—prostate cancer	3.18e-05	0.000308	CcSEcCtD
Ezetimibe—Malaise—Prednisone—prostate cancer	3.18e-05	0.000308	CcSEcCtD
Ezetimibe—Abdominal pain—Etoposide—prostate cancer	3.17e-05	0.000307	CcSEcCtD
Ezetimibe—Body temperature increased—Etoposide—prostate cancer	3.17e-05	0.000307	CcSEcCtD
Ezetimibe—Nervous system disorder—Capecitabine—prostate cancer	3.17e-05	0.000307	CcSEcCtD
Ezetimibe—Hepatitis—Epirubicin—prostate cancer	3.17e-05	0.000307	CcSEcCtD
Ezetimibe—Thrombocytopenia—Capecitabine—prostate cancer	3.16e-05	0.000306	CcSEcCtD
Ezetimibe—Pharyngitis—Epirubicin—prostate cancer	3.14e-05	0.000305	CcSEcCtD
Ezetimibe—Skin disorder—Capecitabine—prostate cancer	3.14e-05	0.000304	CcSEcCtD
Ezetimibe—Oedema peripheral—Epirubicin—prostate cancer	3.12e-05	0.000302	CcSEcCtD
Ezetimibe—Connective tissue disorder—Epirubicin—prostate cancer	3.11e-05	0.000302	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Doxorubicin—prostate cancer	3.09e-05	0.000299	CcSEcCtD
Ezetimibe—Nausea—Estradiol—prostate cancer	3.08e-05	0.000298	CcSEcCtD
Ezetimibe—Vomiting—Mitoxantrone—prostate cancer	3.07e-05	0.000297	CcSEcCtD
Ezetimibe—Sinusitis—Doxorubicin—prostate cancer	3.06e-05	0.000297	CcSEcCtD
Ezetimibe—Hypertension—Prednisone—prostate cancer	3.04e-05	0.000295	CcSEcCtD
Ezetimibe—Rash—Mitoxantrone—prostate cancer	3.04e-05	0.000295	CcSEcCtD
Ezetimibe—Dermatitis—Mitoxantrone—prostate cancer	3.04e-05	0.000295	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.04e-05	0.000294	CcSEcCtD
Ezetimibe—Headache—Mitoxantrone—prostate cancer	3.02e-05	0.000293	CcSEcCtD
Ezetimibe—Insomnia—Docetaxel—prostate cancer	3.02e-05	0.000292	CcSEcCtD
Ezetimibe—Arthralgia—Prednisone—prostate cancer	3e-05	0.000291	CcSEcCtD
Ezetimibe—Myalgia—Prednisone—prostate cancer	3e-05	0.000291	CcSEcCtD
Ezetimibe—Paraesthesia—Docetaxel—prostate cancer	2.99e-05	0.00029	CcSEcCtD
Ezetimibe—Erythema multiforme—Epirubicin—prostate cancer	2.99e-05	0.00029	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.98e-05	0.000289	CcSEcCtD
Ezetimibe—Dyspnoea—Docetaxel—prostate cancer	2.97e-05	0.000288	CcSEcCtD
Ezetimibe—Discomfort—Prednisone—prostate cancer	2.96e-05	0.000287	CcSEcCtD
Ezetimibe—Hypersensitivity—Etoposide—prostate cancer	2.96e-05	0.000287	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.94e-05	0.000285	CcSEcCtD
Ezetimibe—Flushing—Epirubicin—prostate cancer	2.94e-05	0.000285	CcSEcCtD
Ezetimibe—Dyspepsia—Docetaxel—prostate cancer	2.94e-05	0.000285	CcSEcCtD
Ezetimibe—Hepatitis—Doxorubicin—prostate cancer	2.93e-05	0.000284	CcSEcCtD
Ezetimibe—Insomnia—Capecitabine—prostate cancer	2.92e-05	0.000283	CcSEcCtD
Ezetimibe—Pharyngitis—Doxorubicin—prostate cancer	2.91e-05	0.000282	CcSEcCtD
Ezetimibe—Paraesthesia—Capecitabine—prostate cancer	2.9e-05	0.000281	CcSEcCtD
Ezetimibe—Decreased appetite—Docetaxel—prostate cancer	2.9e-05	0.000281	CcSEcCtD
Ezetimibe—Oedema peripheral—Doxorubicin—prostate cancer	2.89e-05	0.00028	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Docetaxel—prostate cancer	2.88e-05	0.000279	CcSEcCtD
Ezetimibe—Asthenia—Etoposide—prostate cancer	2.88e-05	0.000279	CcSEcCtD
Ezetimibe—Connective tissue disorder—Doxorubicin—prostate cancer	2.88e-05	0.000279	CcSEcCtD
Ezetimibe—Dyspnoea—Capecitabine—prostate cancer	2.88e-05	0.000279	CcSEcCtD
Ezetimibe—Anaphylactic shock—Prednisone—prostate cancer	2.88e-05	0.000279	CcSEcCtD
Ezetimibe—Fatigue—Docetaxel—prostate cancer	2.88e-05	0.000279	CcSEcCtD
Ezetimibe—Angiopathy—Epirubicin—prostate cancer	2.87e-05	0.000278	CcSEcCtD
Ezetimibe—Nausea—Mitoxantrone—prostate cancer	2.87e-05	0.000278	CcSEcCtD
Ezetimibe—Immune system disorder—Epirubicin—prostate cancer	2.86e-05	0.000277	CcSEcCtD
Ezetimibe—Infection—Prednisone—prostate cancer	2.86e-05	0.000277	CcSEcCtD
Ezetimibe—Mediastinal disorder—Epirubicin—prostate cancer	2.85e-05	0.000277	CcSEcCtD
Ezetimibe—Pain—Docetaxel—prostate cancer	2.85e-05	0.000276	CcSEcCtD
Ezetimibe—Constipation—Docetaxel—prostate cancer	2.85e-05	0.000276	CcSEcCtD
Ezetimibe—Dyspepsia—Capecitabine—prostate cancer	2.84e-05	0.000275	CcSEcCtD
Ezetimibe—Pruritus—Etoposide—prostate cancer	2.84e-05	0.000275	CcSEcCtD
Ezetimibe—Nervous system disorder—Prednisone—prostate cancer	2.82e-05	0.000273	CcSEcCtD
Ezetimibe—Decreased appetite—Capecitabine—prostate cancer	2.81e-05	0.000272	CcSEcCtD
Ezetimibe—Alopecia—Epirubicin—prostate cancer	2.8e-05	0.000271	CcSEcCtD
Ezetimibe—Skin disorder—Prednisone—prostate cancer	2.79e-05	0.000271	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Capecitabine—prostate cancer	2.79e-05	0.00027	CcSEcCtD
Ezetimibe—Fatigue—Capecitabine—prostate cancer	2.78e-05	0.00027	CcSEcCtD
Ezetimibe—Mental disorder—Epirubicin—prostate cancer	2.77e-05	0.000269	CcSEcCtD
Ezetimibe—Erythema multiforme—Doxorubicin—prostate cancer	2.77e-05	0.000268	CcSEcCtD
Ezetimibe—Pain—Capecitabine—prostate cancer	2.76e-05	0.000268	CcSEcCtD
Ezetimibe—Constipation—Capecitabine—prostate cancer	2.76e-05	0.000268	CcSEcCtD
Ezetimibe—Malnutrition—Epirubicin—prostate cancer	2.76e-05	0.000267	CcSEcCtD
Ezetimibe—Erythema—Epirubicin—prostate cancer	2.76e-05	0.000267	CcSEcCtD
Ezetimibe—Feeling abnormal—Docetaxel—prostate cancer	2.75e-05	0.000266	CcSEcCtD
Ezetimibe—Diarrhoea—Etoposide—prostate cancer	2.75e-05	0.000266	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Docetaxel—prostate cancer	2.73e-05	0.000264	CcSEcCtD
Ezetimibe—Flushing—Doxorubicin—prostate cancer	2.72e-05	0.000264	CcSEcCtD
Ezetimibe—Flatulence—Epirubicin—prostate cancer	2.72e-05	0.000263	CcSEcCtD
Ezetimibe—Back pain—Epirubicin—prostate cancer	2.67e-05	0.000258	CcSEcCtD
Ezetimibe—Feeling abnormal—Capecitabine—prostate cancer	2.66e-05	0.000258	CcSEcCtD
Ezetimibe—Angiopathy—Doxorubicin—prostate cancer	2.66e-05	0.000258	CcSEcCtD
Ezetimibe—Dizziness—Etoposide—prostate cancer	2.65e-05	0.000257	CcSEcCtD
Ezetimibe—Muscle spasms—Epirubicin—prostate cancer	2.65e-05	0.000257	CcSEcCtD
Ezetimibe—Immune system disorder—Doxorubicin—prostate cancer	2.65e-05	0.000256	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Capecitabine—prostate cancer	2.64e-05	0.000256	CcSEcCtD
Ezetimibe—Mediastinal disorder—Doxorubicin—prostate cancer	2.64e-05	0.000256	CcSEcCtD
Ezetimibe—Abdominal pain—Docetaxel—prostate cancer	2.64e-05	0.000256	CcSEcCtD
Ezetimibe—Body temperature increased—Docetaxel—prostate cancer	2.64e-05	0.000256	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Prednisone—prostate cancer	2.62e-05	0.000254	CcSEcCtD
Ezetimibe—Insomnia—Prednisone—prostate cancer	2.6e-05	0.000252	CcSEcCtD
Ezetimibe—Alopecia—Doxorubicin—prostate cancer	2.59e-05	0.000251	CcSEcCtD
Ezetimibe—Paraesthesia—Prednisone—prostate cancer	2.58e-05	0.00025	CcSEcCtD
Ezetimibe—Mental disorder—Doxorubicin—prostate cancer	2.57e-05	0.000249	CcSEcCtD
Ezetimibe—Urticaria—Capecitabine—prostate cancer	2.57e-05	0.000249	CcSEcCtD
Ezetimibe—Ill-defined disorder—Epirubicin—prostate cancer	2.56e-05	0.000248	CcSEcCtD
Ezetimibe—Abdominal pain—Capecitabine—prostate cancer	2.55e-05	0.000247	CcSEcCtD
Ezetimibe—Body temperature increased—Capecitabine—prostate cancer	2.55e-05	0.000247	CcSEcCtD
Ezetimibe—Vomiting—Etoposide—prostate cancer	2.55e-05	0.000247	CcSEcCtD
Ezetimibe—Malnutrition—Doxorubicin—prostate cancer	2.55e-05	0.000247	CcSEcCtD
Ezetimibe—Erythema—Doxorubicin—prostate cancer	2.55e-05	0.000247	CcSEcCtD
Ezetimibe—Anaemia—Epirubicin—prostate cancer	2.55e-05	0.000247	CcSEcCtD
Ezetimibe—Dyspepsia—Prednisone—prostate cancer	2.53e-05	0.000245	CcSEcCtD
Ezetimibe—Rash—Etoposide—prostate cancer	2.53e-05	0.000245	CcSEcCtD
Ezetimibe—Dermatitis—Etoposide—prostate cancer	2.53e-05	0.000245	CcSEcCtD
Ezetimibe—Headache—Etoposide—prostate cancer	2.51e-05	0.000244	CcSEcCtD
Ezetimibe—Flatulence—Doxorubicin—prostate cancer	2.51e-05	0.000244	CcSEcCtD
Ezetimibe—Decreased appetite—Prednisone—prostate cancer	2.5e-05	0.000242	CcSEcCtD
Ezetimibe—Malaise—Epirubicin—prostate cancer	2.49e-05	0.000241	CcSEcCtD
Ezetimibe—Fatigue—Prednisone—prostate cancer	2.48e-05	0.00024	CcSEcCtD
Ezetimibe—Back pain—Doxorubicin—prostate cancer	2.47e-05	0.000239	CcSEcCtD
Ezetimibe—Constipation—Prednisone—prostate cancer	2.46e-05	0.000238	CcSEcCtD
Ezetimibe—Hypersensitivity—Docetaxel—prostate cancer	2.46e-05	0.000238	CcSEcCtD
Ezetimibe—Muscle spasms—Doxorubicin—prostate cancer	2.45e-05	0.000238	CcSEcCtD
Ezetimibe—Palpitations—Epirubicin—prostate cancer	2.44e-05	0.000236	CcSEcCtD
Ezetimibe—Cough—Epirubicin—prostate cancer	2.41e-05	0.000233	CcSEcCtD
Ezetimibe—Asthenia—Docetaxel—prostate cancer	2.39e-05	0.000232	CcSEcCtD
Ezetimibe—Nausea—Etoposide—prostate cancer	2.38e-05	0.000231	CcSEcCtD
Ezetimibe—Hypertension—Epirubicin—prostate cancer	2.38e-05	0.000231	CcSEcCtD
Ezetimibe—Hypersensitivity—Capecitabine—prostate cancer	2.38e-05	0.000231	CcSEcCtD
Ezetimibe—Feeling abnormal—Prednisone—prostate cancer	2.37e-05	0.00023	CcSEcCtD
Ezetimibe—Ill-defined disorder—Doxorubicin—prostate cancer	2.37e-05	0.000229	CcSEcCtD
Ezetimibe—Pruritus—Docetaxel—prostate cancer	2.36e-05	0.000229	CcSEcCtD
Ezetimibe—Anaemia—Doxorubicin—prostate cancer	2.36e-05	0.000228	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Prednisone—prostate cancer	2.35e-05	0.000228	CcSEcCtD
Ezetimibe—Arthralgia—Epirubicin—prostate cancer	2.35e-05	0.000227	CcSEcCtD
Ezetimibe—Chest pain—Epirubicin—prostate cancer	2.35e-05	0.000227	CcSEcCtD
Ezetimibe—Myalgia—Epirubicin—prostate cancer	2.35e-05	0.000227	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.33e-05	0.000226	CcSEcCtD
Ezetimibe—Discomfort—Epirubicin—prostate cancer	2.32e-05	0.000225	CcSEcCtD
Ezetimibe—Asthenia—Capecitabine—prostate cancer	2.32e-05	0.000225	CcSEcCtD
Ezetimibe—Malaise—Doxorubicin—prostate cancer	2.3e-05	0.000223	CcSEcCtD
Ezetimibe—Dry mouth—Epirubicin—prostate cancer	2.29e-05	0.000222	CcSEcCtD
Ezetimibe—Urticaria—Prednisone—prostate cancer	2.28e-05	0.000221	CcSEcCtD
Ezetimibe—Pruritus—Capecitabine—prostate cancer	2.28e-05	0.000221	CcSEcCtD
Ezetimibe—Diarrhoea—Docetaxel—prostate cancer	2.28e-05	0.000221	CcSEcCtD
Ezetimibe—Abdominal pain—Prednisone—prostate cancer	2.27e-05	0.00022	CcSEcCtD
Ezetimibe—Body temperature increased—Prednisone—prostate cancer	2.27e-05	0.00022	CcSEcCtD
Ezetimibe—Confusional state—Epirubicin—prostate cancer	2.27e-05	0.00022	CcSEcCtD
Ezetimibe—Palpitations—Doxorubicin—prostate cancer	2.25e-05	0.000218	CcSEcCtD
Ezetimibe—Anaphylactic shock—Epirubicin—prostate cancer	2.25e-05	0.000218	CcSEcCtD
Ezetimibe—Infection—Epirubicin—prostate cancer	2.23e-05	0.000217	CcSEcCtD
Ezetimibe—Cough—Doxorubicin—prostate cancer	2.23e-05	0.000216	CcSEcCtD
Ezetimibe—Diarrhoea—Capecitabine—prostate cancer	2.21e-05	0.000214	CcSEcCtD
Ezetimibe—Nervous system disorder—Epirubicin—prostate cancer	2.21e-05	0.000214	CcSEcCtD
Ezetimibe—Dizziness—Docetaxel—prostate cancer	2.21e-05	0.000214	CcSEcCtD
Ezetimibe—Thrombocytopenia—Epirubicin—prostate cancer	2.2e-05	0.000213	CcSEcCtD
Ezetimibe—Hypertension—Doxorubicin—prostate cancer	2.2e-05	0.000213	CcSEcCtD
Ezetimibe—Skin disorder—Epirubicin—prostate cancer	2.18e-05	0.000212	CcSEcCtD
Ezetimibe—Chest pain—Doxorubicin—prostate cancer	2.17e-05	0.00021	CcSEcCtD
Ezetimibe—Arthralgia—Doxorubicin—prostate cancer	2.17e-05	0.00021	CcSEcCtD
Ezetimibe—Myalgia—Doxorubicin—prostate cancer	2.17e-05	0.00021	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.16e-05	0.000209	CcSEcCtD
Ezetimibe—Discomfort—Doxorubicin—prostate cancer	2.15e-05	0.000208	CcSEcCtD
Ezetimibe—Dizziness—Capecitabine—prostate cancer	2.14e-05	0.000207	CcSEcCtD
Ezetimibe—Dry mouth—Doxorubicin—prostate cancer	2.12e-05	0.000206	CcSEcCtD
Ezetimibe—Vomiting—Docetaxel—prostate cancer	2.12e-05	0.000206	CcSEcCtD
Ezetimibe—Hypersensitivity—Prednisone—prostate cancer	2.12e-05	0.000205	CcSEcCtD
Ezetimibe—Rash—Docetaxel—prostate cancer	2.1e-05	0.000204	CcSEcCtD
Ezetimibe—Dermatitis—Docetaxel—prostate cancer	2.1e-05	0.000204	CcSEcCtD
Ezetimibe—Confusional state—Doxorubicin—prostate cancer	2.1e-05	0.000203	CcSEcCtD
Ezetimibe—Headache—Docetaxel—prostate cancer	2.09e-05	0.000202	CcSEcCtD
Ezetimibe—Anaphylactic shock—Doxorubicin—prostate cancer	2.08e-05	0.000202	CcSEcCtD
Ezetimibe—Infection—Doxorubicin—prostate cancer	2.07e-05	0.0002	CcSEcCtD
Ezetimibe—Asthenia—Prednisone—prostate cancer	2.06e-05	0.0002	CcSEcCtD
Ezetimibe—Vomiting—Capecitabine—prostate cancer	2.05e-05	0.000199	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.05e-05	0.000199	CcSEcCtD
Ezetimibe—Nervous system disorder—Doxorubicin—prostate cancer	2.04e-05	0.000198	CcSEcCtD
Ezetimibe—Thrombocytopenia—Doxorubicin—prostate cancer	2.04e-05	0.000198	CcSEcCtD
Ezetimibe—Rash—Capecitabine—prostate cancer	2.04e-05	0.000197	CcSEcCtD
Ezetimibe—Pruritus—Prednisone—prostate cancer	2.03e-05	0.000197	CcSEcCtD
Ezetimibe—Insomnia—Epirubicin—prostate cancer	2.03e-05	0.000197	CcSEcCtD
Ezetimibe—Dermatitis—Capecitabine—prostate cancer	2.03e-05	0.000197	CcSEcCtD
Ezetimibe—Headache—Capecitabine—prostate cancer	2.02e-05	0.000196	CcSEcCtD
Ezetimibe—Skin disorder—Doxorubicin—prostate cancer	2.02e-05	0.000196	CcSEcCtD
Ezetimibe—Paraesthesia—Epirubicin—prostate cancer	2.02e-05	0.000196	CcSEcCtD
Ezetimibe—Dyspnoea—Epirubicin—prostate cancer	2.01e-05	0.000194	CcSEcCtD
Ezetimibe—Nausea—Docetaxel—prostate cancer	1.98e-05	0.000192	CcSEcCtD
Ezetimibe—Dyspepsia—Epirubicin—prostate cancer	1.98e-05	0.000192	CcSEcCtD
Ezetimibe—Diarrhoea—Prednisone—prostate cancer	1.97e-05	0.000191	CcSEcCtD
Ezetimibe—Decreased appetite—Epirubicin—prostate cancer	1.96e-05	0.00019	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Epirubicin—prostate cancer	1.94e-05	0.000188	CcSEcCtD
Ezetimibe—Fatigue—Epirubicin—prostate cancer	1.94e-05	0.000188	CcSEcCtD
Ezetimibe—Pain—Epirubicin—prostate cancer	1.92e-05	0.000186	CcSEcCtD
Ezetimibe—Constipation—Epirubicin—prostate cancer	1.92e-05	0.000186	CcSEcCtD
Ezetimibe—Nausea—Capecitabine—prostate cancer	1.92e-05	0.000186	CcSEcCtD
Ezetimibe—Dizziness—Prednisone—prostate cancer	1.9e-05	0.000184	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.9e-05	0.000184	CcSEcCtD
Ezetimibe—Insomnia—Doxorubicin—prostate cancer	1.88e-05	0.000182	CcSEcCtD
Ezetimibe—Paraesthesia—Doxorubicin—prostate cancer	1.87e-05	0.000181	CcSEcCtD
Ezetimibe—Dyspnoea—Doxorubicin—prostate cancer	1.86e-05	0.00018	CcSEcCtD
Ezetimibe—Feeling abnormal—Epirubicin—prostate cancer	1.85e-05	0.00018	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Epirubicin—prostate cancer	1.84e-05	0.000178	CcSEcCtD
Ezetimibe—Dyspepsia—Doxorubicin—prostate cancer	1.83e-05	0.000178	CcSEcCtD
Ezetimibe—Vomiting—Prednisone—prostate cancer	1.83e-05	0.000177	CcSEcCtD
Ezetimibe—Rash—Prednisone—prostate cancer	1.81e-05	0.000176	CcSEcCtD
Ezetimibe—Dermatitis—Prednisone—prostate cancer	1.81e-05	0.000176	CcSEcCtD
Ezetimibe—Decreased appetite—Doxorubicin—prostate cancer	1.81e-05	0.000175	CcSEcCtD
Ezetimibe—Headache—Prednisone—prostate cancer	1.8e-05	0.000175	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.8e-05	0.000174	CcSEcCtD
Ezetimibe—Fatigue—Doxorubicin—prostate cancer	1.79e-05	0.000174	CcSEcCtD
Ezetimibe—Urticaria—Epirubicin—prostate cancer	1.79e-05	0.000173	CcSEcCtD
Ezetimibe—Pain—Doxorubicin—prostate cancer	1.78e-05	0.000172	CcSEcCtD
Ezetimibe—Constipation—Doxorubicin—prostate cancer	1.78e-05	0.000172	CcSEcCtD
Ezetimibe—Abdominal pain—Epirubicin—prostate cancer	1.78e-05	0.000172	CcSEcCtD
Ezetimibe—Body temperature increased—Epirubicin—prostate cancer	1.78e-05	0.000172	CcSEcCtD
Ezetimibe—Feeling abnormal—Doxorubicin—prostate cancer	1.72e-05	0.000166	CcSEcCtD
Ezetimibe—Nausea—Prednisone—prostate cancer	1.71e-05	0.000166	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Doxorubicin—prostate cancer	1.7e-05	0.000165	CcSEcCtD
Ezetimibe—Hypersensitivity—Epirubicin—prostate cancer	1.66e-05	0.000161	CcSEcCtD
Ezetimibe—Urticaria—Doxorubicin—prostate cancer	1.65e-05	0.00016	CcSEcCtD
Ezetimibe—Body temperature increased—Doxorubicin—prostate cancer	1.65e-05	0.000159	CcSEcCtD
Ezetimibe—Abdominal pain—Doxorubicin—prostate cancer	1.65e-05	0.000159	CcSEcCtD
Ezetimibe—Asthenia—Epirubicin—prostate cancer	1.61e-05	0.000156	CcSEcCtD
Ezetimibe—Pruritus—Epirubicin—prostate cancer	1.59e-05	0.000154	CcSEcCtD
Ezetimibe—Diarrhoea—Epirubicin—prostate cancer	1.54e-05	0.000149	CcSEcCtD
Ezetimibe—Hypersensitivity—Doxorubicin—prostate cancer	1.53e-05	0.000149	CcSEcCtD
Ezetimibe—Asthenia—Doxorubicin—prostate cancer	1.49e-05	0.000145	CcSEcCtD
Ezetimibe—Dizziness—Epirubicin—prostate cancer	1.49e-05	0.000144	CcSEcCtD
Ezetimibe—Pruritus—Doxorubicin—prostate cancer	1.47e-05	0.000143	CcSEcCtD
Ezetimibe—Vomiting—Epirubicin—prostate cancer	1.43e-05	0.000139	CcSEcCtD
Ezetimibe—Diarrhoea—Doxorubicin—prostate cancer	1.42e-05	0.000138	CcSEcCtD
Ezetimibe—Rash—Epirubicin—prostate cancer	1.42e-05	0.000137	CcSEcCtD
Ezetimibe—Dermatitis—Epirubicin—prostate cancer	1.42e-05	0.000137	CcSEcCtD
Ezetimibe—Headache—Epirubicin—prostate cancer	1.41e-05	0.000137	CcSEcCtD
Ezetimibe—Dizziness—Doxorubicin—prostate cancer	1.38e-05	0.000133	CcSEcCtD
Ezetimibe—Nausea—Epirubicin—prostate cancer	1.34e-05	0.000129	CcSEcCtD
Ezetimibe—Vomiting—Doxorubicin—prostate cancer	1.32e-05	0.000128	CcSEcCtD
Ezetimibe—Rash—Doxorubicin—prostate cancer	1.31e-05	0.000127	CcSEcCtD
Ezetimibe—Dermatitis—Doxorubicin—prostate cancer	1.31e-05	0.000127	CcSEcCtD
Ezetimibe—Headache—Doxorubicin—prostate cancer	1.3e-05	0.000126	CcSEcCtD
Ezetimibe—Nausea—Doxorubicin—prostate cancer	1.24e-05	0.00012	CcSEcCtD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.88e-06	1.92e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.87e-06	1.91e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.87e-06	1.9e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CAV1—prostate cancer	1.86e-06	1.9e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CAV1—prostate cancer	1.86e-06	1.9e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—COMT—prostate cancer	1.86e-06	1.9e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTM1—prostate cancer	1.86e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TBXAS1—prostate cancer	1.86e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA4—prostate cancer	1.86e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP19A1—prostate cancer	1.85e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTP1—prostate cancer	1.85e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CREBBP—prostate cancer	1.85e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.85e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.83e-06	1.87e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—LPL—prostate cancer	1.82e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ITPR1—prostate cancer	1.82e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA2—prostate cancer	1.81e-06	1.84e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.79e-06	1.83e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—RXRA—prostate cancer	1.79e-06	1.82e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCG5—prostate cancer	1.79e-06	1.82e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SULT1A1—prostate cancer	1.79e-06	1.82e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.78e-06	1.81e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP1A1—prostate cancer	1.76e-06	1.79e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CD—prostate cancer	1.75e-06	1.79e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ERCC2—prostate cancer	1.75e-06	1.78e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA1—prostate cancer	1.74e-06	1.78e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CA—prostate cancer	1.74e-06	1.77e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.73e-06	1.76e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NAT2—prostate cancer	1.72e-06	1.76e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HSD3B2—prostate cancer	1.72e-06	1.76e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTO1—prostate cancer	1.72e-06	1.76e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—COMT—prostate cancer	1.72e-06	1.76e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TYMS—prostate cancer	1.72e-06	1.76e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTP1—prostate cancer	1.71e-06	1.75e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTM1—prostate cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CG—prostate cancer	1.7e-06	1.73e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CG—prostate cancer	1.7e-06	1.73e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ITPR1—prostate cancer	1.69e-06	1.72e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—LPL—prostate cancer	1.67e-06	1.7e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NOS3—prostate cancer	1.66e-06	1.69e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLCB2—prostate cancer	1.65e-06	1.69e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LRP2—prostate cancer	1.65e-06	1.69e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2C18—prostate cancer	1.65e-06	1.69e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.65e-06	1.68e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HPGD—prostate cancer	1.65e-06	1.68e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MTHFR—prostate cancer	1.64e-06	1.67e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—P4HB—prostate cancer	1.62e-06	1.65e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP1A1—prostate cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARA—prostate cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—INS—prostate cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—INS—prostate cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ERCC2—prostate cancer	1.6e-06	1.63e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TYMS—prostate cancer	1.59e-06	1.63e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.59e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC22A1—prostate cancer	1.58e-06	1.61e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.58e-06	1.61e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTM1—prostate cancer	1.58e-06	1.61e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CREBBP—prostate cancer	1.57e-06	1.6e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CREBBP—prostate cancer	1.57e-06	1.6e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.55e-06	1.58e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LPL—prostate cancer	1.55e-06	1.58e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SULT2A1—prostate cancer	1.54e-06	1.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.54e-06	1.57e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CB—prostate cancer	1.53e-06	1.56e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—prostate cancer	1.52e-06	1.54e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CAV1—prostate cancer	1.51e-06	1.54e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MED12—prostate cancer	1.51e-06	1.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTAP—prostate cancer	1.51e-06	1.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.51e-06	1.54e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MTHFR—prostate cancer	1.5e-06	1.53e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GNG5—prostate cancer	1.5e-06	1.53e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP1A1—prostate cancer	1.49e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CD—prostate cancer	1.49e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CD—prostate cancer	1.49e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ERCC2—prostate cancer	1.48e-06	1.51e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARA—prostate cancer	1.48e-06	1.5e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.47e-06	1.5e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.47e-06	1.5e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NCOA3—prostate cancer	1.45e-06	1.47e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—prostate cancer	1.42e-06	1.45e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NOS3—prostate cancer	1.41e-06	1.44e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NOS3—prostate cancer	1.41e-06	1.44e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ACSL4—prostate cancer	1.4e-06	1.43e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.4e-06	1.43e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MTHFR—prostate cancer	1.39e-06	1.42e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CAV1—prostate cancer	1.39e-06	1.41e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CG—prostate cancer	1.38e-06	1.41e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HPGDS—prostate cancer	1.38e-06	1.41e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2C19—prostate cancer	1.37e-06	1.4e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARA—prostate cancer	1.37e-06	1.39e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ARG2—prostate cancer	1.34e-06	1.37e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—UMPS—prostate cancer	1.34e-06	1.37e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PHGDH—prostate cancer	1.34e-06	1.37e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTT1—prostate cancer	1.34e-06	1.36e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ACHE—prostate cancer	1.34e-06	1.36e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.33e-06	1.35e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2A6—prostate cancer	1.32e-06	1.35e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTEN—prostate cancer	1.32e-06	1.35e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LDHB—prostate cancer	1.32e-06	1.34e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—INS—prostate cancer	1.31e-06	1.33e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CB—prostate cancer	1.3e-06	1.33e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CB—prostate cancer	1.3e-06	1.33e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.3e-06	1.32e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.29e-06	1.32e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—prostate cancer	1.29e-06	1.31e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—prostate cancer	1.29e-06	1.31e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKR1C3—prostate cancer	1.29e-06	1.31e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CAV1—prostate cancer	1.28e-06	1.31e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PRKACB—prostate cancer	1.28e-06	1.3e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CREBBP—prostate cancer	1.28e-06	1.3e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP17A1—prostate cancer	1.27e-06	1.29e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CG—prostate cancer	1.26e-06	1.29e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—EP300—prostate cancer	1.26e-06	1.28e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.25e-06	1.28e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PDHA1—prostate cancer	1.25e-06	1.27e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA3—prostate cancer	1.25e-06	1.27e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—UCP3—prostate cancer	1.25e-06	1.27e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TCN2—prostate cancer	1.25e-06	1.27e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CD—prostate cancer	1.21e-06	1.24e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NCOA2—prostate cancer	1.21e-06	1.23e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—INS—prostate cancer	1.2e-06	1.22e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.19e-06	1.22e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.19e-06	1.22e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CREBBP—prostate cancer	1.17e-06	1.19e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CG—prostate cancer	1.17e-06	1.19e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SLC5A5—prostate cancer	1.15e-06	1.17e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NOS3—prostate cancer	1.14e-06	1.17e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA4—prostate cancer	1.14e-06	1.17e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.14e-06	1.17e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2E1—prostate cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTEN—prostate cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTEN—prostate cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA2—prostate cancer	1.11e-06	1.14e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NQO1—prostate cancer	1.11e-06	1.13e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CD—prostate cancer	1.11e-06	1.13e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—INS—prostate cancer	1.11e-06	1.13e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.1e-06	1.12e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCG5—prostate cancer	1.1e-06	1.12e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TH—prostate cancer	1.1e-06	1.12e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CREBBP—prostate cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP3A4—prostate cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA1—prostate cancer	1.07e-06	1.1e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—EP300—prostate cancer	1.07e-06	1.09e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—EP300—prostate cancer	1.07e-06	1.09e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1B1—prostate cancer	1.07e-06	1.09e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTO1—prostate cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NAT2—prostate cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CB—prostate cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NOS3—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GGT1—prostate cancer	1.03e-06	1.05e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CD—prostate cancer	1.03e-06	1.05e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LRP2—prostate cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLCB2—prostate cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NCOA1—prostate cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP19A1—prostate cancer	1e-06	1.02e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—P4HB—prostate cancer	9.99e-07	1.02e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC22A1—prostate cancer	9.72e-07	9.91e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NOS3—prostate cancer	9.71e-07	9.9e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CB—prostate cancer	9.68e-07	9.87e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—RXRA—prostate cancer	9.67e-07	9.86e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—prostate cancer	9.59e-07	9.78e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SULT2A1—prostate cancer	9.47e-07	9.66e-06	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CA—prostate cancer	9.32e-07	9.51e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MED12—prostate cancer	9.32e-07	9.5e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—COMT—prostate cancer	9.31e-07	9.5e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTP1—prostate cancer	9.27e-07	9.45e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GNG5—prostate cancer	9.24e-07	9.43e-06	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTEN—prostate cancer	9.13e-07	9.31e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ITPR1—prostate cancer	9.12e-07	9.3e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CB—prostate cancer	8.96e-07	9.14e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOA3—prostate cancer	8.9e-07	9.08e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—prostate cancer	8.88e-07	9.06e-06	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—EP300—prostate cancer	8.71e-07	8.88e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TYMS—prostate cancer	8.62e-07	8.79e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTM1—prostate cancer	8.52e-07	8.69e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HPGDS—prostate cancer	8.49e-07	8.66e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2C19—prostate cancer	8.44e-07	8.61e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTEN—prostate cancer	8.37e-07	8.53e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LPL—prostate cancer	8.36e-07	8.53e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ACHE—prostate cancer	8.24e-07	8.4e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTT1—prostate cancer	8.24e-07	8.4e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2A6—prostate cancer	8.14e-07	8.3e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1A1—prostate cancer	8.08e-07	8.23e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ERCC2—prostate cancer	8.01e-07	8.17e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—EP300—prostate cancer	7.98e-07	8.14e-06	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CA—prostate cancer	7.93e-07	8.08e-06	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CA—prostate cancer	7.93e-07	8.08e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKR1C3—prostate cancer	7.92e-07	8.08e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PRKACB—prostate cancer	7.88e-07	8.04e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.8e-07	7.95e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTEN—prostate cancer	7.75e-07	7.9e-06	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—prostate cancer	7.61e-07	7.76e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTHFR—prostate cancer	7.53e-07	7.68e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOA2—prostate cancer	7.43e-07	7.58e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—EP300—prostate cancer	7.39e-07	7.53e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARA—prostate cancer	7.39e-07	7.53e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SLC5A5—prostate cancer	7.09e-07	7.23e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CAV1—prostate cancer	6.94e-07	7.08e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.92e-07	7.06e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NQO1—prostate cancer	6.85e-07	6.98e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TH—prostate cancer	6.75e-07	6.88e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1B1—prostate cancer	6.56e-07	6.69e-06	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—prostate cancer	6.47e-07	6.6e-06	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—prostate cancer	6.47e-07	6.6e-06	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CA—prostate cancer	6.44e-07	6.57e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GGT1—prostate cancer	6.36e-07	6.48e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CG—prostate cancer	6.33e-07	6.45e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOA1—prostate cancer	6.26e-07	6.39e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP19A1—prostate cancer	6.17e-07	6.29e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—INS—prostate cancer	5.99e-07	6.11e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—RXRA—prostate cancer	5.96e-07	6.07e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CA—prostate cancer	5.9e-07	6.02e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CREBBP—prostate cancer	5.86e-07	5.98e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—COMT—prostate cancer	5.74e-07	5.85e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTP1—prostate cancer	5.71e-07	5.82e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ITPR1—prostate cancer	5.62e-07	5.73e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CD—prostate cancer	5.56e-07	5.67e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CA—prostate cancer	5.46e-07	5.57e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TYMS—prostate cancer	5.31e-07	5.41e-06	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—prostate cancer	5.26e-07	5.36e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NOS3—prostate cancer	5.25e-07	5.35e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM1—prostate cancer	5.25e-07	5.35e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LPL—prostate cancer	5.15e-07	5.25e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.98e-07	5.07e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ERCC2—prostate cancer	4.93e-07	5.03e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CB—prostate cancer	4.85e-07	4.94e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—prostate cancer	4.82e-07	4.92e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—prostate cancer	4.8e-07	4.9e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTHFR—prostate cancer	4.64e-07	4.73e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARA—prostate cancer	4.55e-07	4.64e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—prostate cancer	4.46e-07	4.55e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CAV1—prostate cancer	4.28e-07	4.36e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTEN—prostate cancer	4.19e-07	4.27e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—EP300—prostate cancer	3.99e-07	4.07e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.9e-07	3.97e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—INS—prostate cancer	3.69e-07	3.76e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CREBBP—prostate cancer	3.61e-07	3.68e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.43e-07	3.49e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NOS3—prostate cancer	3.23e-07	3.3e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.99e-07	3.04e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—prostate cancer	2.96e-07	3.02e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CA—prostate cancer	2.95e-07	3.01e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTEN—prostate cancer	2.58e-07	2.63e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—EP300—prostate cancer	2.46e-07	2.51e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—prostate cancer	2.41e-07	2.46e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.82e-07	1.86e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—prostate cancer	1.49e-07	1.52e-06	CbGpPWpGaD
